Published in Br Med J on February 24, 1973
Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Malar J (2008) 1.86
The disposition of amodiaquine in man after oral administration. Br J Clin Pharmacol (1987) 1.49
Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents. Br Med J (Clin Res Ed) (1986) 1.07
Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro. Antimicrob Agents Chemother (1988) 0.99
Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studies. Br J Cancer (1986) 0.90
The toxicity of amodiaquine and its principal metabolites towards mononuclear leucocytes and granulocyte/monocyte colony forming units. Br J Clin Pharmacol (1990) 0.88
Quinine-induced agranulocytosis: toxic effect of quinine bisulphate on bone marrow cultures in vitro. Br Med J (1977) 0.86
Effect of monodesethyl amodiaquine on human polymorphonuclear neutrophil functions in vitro. Antimicrob Agents Chemother (1991) 0.80
Amodiaquine-associated adverse effects after inadvertent overdose and after a standard therapeutic dose. Ghana Med J (2009) 0.80
Heterologous aortic valve transplantation. Lancet (1965) 1.93
Fatal agranulocytosis during treatment with a amodiaquine. Br Med J (1957) 1.84
Absolute neutrophil leucopenia after uncontrolled use of amodiaquine. Br Med J (1955) 1.74
Nearly fatal reaction to amodiaquine. JAMA (1962) 1.59
Evaluation of amodiaquin (camoquin) in the treatment of relapsing vivax malaria. Am J Med Sci (1953) 1.56
Hydroxychloroquine-induced agranulocytosis. Arch Dermatol (1968) 1.14
Agranulocytosis coincident with amodiaquine therapy. Br Med J (1967) 1.13
Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res (1999) 2.04
Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res (1997) 1.95
Sequence relationships of three human satellite DNAs. J Mol Biol (1986) 1.93
Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer (1997) 1.93
Australian multicentre phase II trial of paclitaxel in women with metastatic breast cancer and prior chemotherapy. Med J Aust (1997) 1.40
Long-term bone marrow culture induces terminal differentiation of human myeloid leukemic cells. Exp Hematol (1987) 1.39
A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol (1987) 1.26
The mechanism of neutropenia in Felty's syndrome. Br J Haematol (1974) 1.22
The Sézary syndrome: cytogenetic studies and identification of the Sézary Cell as an abnormal lymphocyte. Am J Med (1971) 1.14
Hypermethylation of E-cadherin in leukemia. Blood (2000) 1.12
Simple repeated sequences in human satellite DNA. Nucleic Acids Res (1982) 1.11
Management of mycosis fungoides--current status and future prospects. Medicine (Baltimore) (1975) 1.05
Changes in body composition during breast cancer chemotherapy with the CMF-regimen. Breast Cancer Res Treat (1999) 1.04
The predictive value of body protein for chemotherapy-induced toxicity. Cancer (2000) 1.04
Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms. Drugs (1986) 1.03
Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group. Lancet (2001) 1.03
Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme. J Neurooncol (2001) 1.02
Control of lymphocyte level in the blood. Lancet (1970) 0.98
Human satellite I sequences include a male specific 2.47 kb tandemly repeated unit containing one Alu family member per repeat. Nucleic Acids Res (1984) 0.96
The non-equivalence of mouse and human marrow culture in the assay of granulopoietic stimulatory factors. J Cell Physiol (1974) 0.95
Combination chemotherapy of advanced previously treated Hodgkin's disease with streptozotocin, CCNU, adriamycin and bleomycin. Med Pediatr Oncol (1977) 0.94
Advanced ovarian cancer: a prospective randomised trial of chlorambucil versus combined cyclophosphamide and cis-diamminedichloroplatinum. Aust N Z J Med (1982) 0.92
Superior vena caval obstruction: a 10-year experience. Med J Aust (1987) 0.92
Metastatic adenocarcinomas of unknown primary site: a randomized study of two combination-chemotherapy regimens. N Engl J Med (1980) 0.92
Cancer-specific region of hypermethylation identified within the HIC1 putative tumour suppressor gene in acute myeloid leukaemia. Leukemia (1999) 0.91
Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimens. Eur J Cancer Clin Oncol (1987) 0.91
Bladder cancer xenografts: a model of tumor cell heterogeneity. Cancer Res (1986) 0.89
Comparison of the growth of the Ehrlich ascites tumor in male and female mice. Cancer Res (1967) 0.87
Thirteen cases of leukemia in a family. J Natl Cancer Inst (1978) 0.87
Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies. J Clin Oncol (1986) 0.87
Extranodal presentation of non-Hodgkin's lymphomas in the testis. Cancer (1976) 0.87
Quinine-induced agranulocytosis: toxic effect of quinine bisulphate on bone marrow cultures in vitro. Br Med J (1977) 0.86
Increased DNA methyltransferase expression in leukaemia. Leukemia (1998) 0.86
Assessment of the value of lysozyme assay in neutropenia. Br J Haematol (1973) 0.86
Improved combination chemotherapy in advanced gastric cancer. Br Med J (1979) 0.86
Meningeal carcinomatosis in small cell carcinoma of the lung. Am J Med (1981) 0.85
Bleomycin pulmonary toxicity: its relationship to renal dysfunction. Med Pediatr Oncol (1984) 0.85
Haemolytic anaemia after cisplatin treatment. Br Med J (Clin Res Ed) (1981) 0.84
Studies on muramidase in hematologic disorders. I. Serum muramidase and serum lactic dehydrogenase in leukemia. Cancer (1973) 0.84
Drug-induced agranulocytosis. Clin Haematol (1980) 0.84
Lymphocyte kinetics in chronic lymphocytic leukaemia (CLL) studied by ECIB. Br J Haematol (1969) 0.84
Disseminated atypical mycobacterial infection in hairy cell leukemia. Pathology (1983) 0.84
Prophylactic oral antibiotics in the management of acute leukaemia. Med J Aust (1973) 0.83
Cytogenetic abnormalities in benign lymphoid hyperplasia: a dual-parameter study using chromosome analysis and flow cytometry. Int J Cancer (1989) 0.83
Granulocyte kinetics in health and disease. Clin Haematol (1977) 0.83
A case of dysphagia due to post-cricoid web in a patient with pernicious anaemia without iron deficiency. Med J Aust (1966) 0.82
Long-term follow-up of a randomised trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lung. Eur J Cancer (1996) 0.82
The intravascular survival of neutrophils labeled in vivo. Blood (1974) 0.82
Modified neutropenic response to re-used dialyzers in patients with chronic renal failure. Clin Nephrol (1977) 0.82
Changes in body composition during adjuvant chemotherapy for breast cancer. Appl Radiat Isot (1998) 0.82
Inhibition of normal human granulopoiesis in vitro by non-B non-T lymphocytes. Br J Haematol (1980) 0.82
The generation time of human leukemic myeloblasts. Lab Invest (1972) 0.81
Malignant melanoma: analysis by DNA flow cytometry. Pathology (1985) 0.81
Plasma lactoferrin in patients with neutropenia. Blut (1986) 0.81
Buoyant density and hybridization analysis of human DNA sequences, including three satellite DNAs. Biochim Biophys Acta (1981) 0.81
In vitro evidence of drug action in aplastic anemia. Blut (1984) 0.80
Leukocyte kinetics in chronic myeloid leukemia. I. DNA synthesis time in blood and marrow myelocytes. Blood (1969) 0.80
Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease. Cancer (1977) 0.80
Advantage of reduced oxygen tension in growth of human melanomas in semi-solid cultures: quantitative analysis. Br J Cancer (1983) 0.80
The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease. Cancer (1977) 0.80
In vitro studies of leukocyte labeling with technetium-99m. J Nucl Med (1976) 0.79
Combination chemotherapy with cyclophosphamide, doxorubicin, and bleomycin for metastatic transitional cell carcinoma of the urinary tract. Cancer Treat Rep (1981) 0.78
The effect of large doses of calcium carbonate on serum and urinary calcium. Am J Dig Dis (1966) 0.78
Quantitative studies on the response of normal and leukaemic lymphocytes to phytohaemagglutinin. Aust J Exp Biol Med Sci (1974) 0.78
Isotypic discordance of paraproteins and lymphocyte surface immunoglobulins in myeloma. Blood (1981) 0.78
Ph1 negative haematological chimaerism after marrow transplantation in Ph1 positive chronic granulocytic leukaemia. Br J Haematol (1986) 0.78
Serum galactosyltransferase isoenzymes as markers for solid tumours in humans. Eur J Cancer Clin Oncol (1984) 0.78
Characterization of endocrine-rich monolayers of human fetal pancreas that display reduced immunogenicity. Diabetes (1991) 0.78
Blood volume in malignant disease: case studies in 86 females. Aust N Z J Surg (1968) 0.78
Dying of cancer. Factors influencing the place of death of patients. Med J Aust (1984) 0.78
Semi-solid cultures of primary melanomas and their correlation with histopathological features. Pathology (1985) 0.78
The CFU-C assay in patients with neutropenia and, in particular, drug associated neutropenia. Clin Lab Haematol (1987) 0.78
Limited extranodal Hodgkin's disease. Unfavorable prognosis and therapeutic implications. Am J Med (1977) 0.78
Treatment of malignant meningeal disease with intrathecal thioTEPA: a phase II study. Cancer Treat Rep (1977) 0.78
Cell cycle homogeneity in bone marrow samples from different sites: flow cytometric evaluation of multiple samples from sheep. Exp Hematol (1983) 0.78
The significance of abnormal circulating cells in patients with Hodgkin's disease. Br J Haematol (1975) 0.77
Letter: Problems with filtration-collected neutrophils. N Engl J Med (1976) 0.77
Chemotherapy of adult soft tissue sarcoma with combination of doxorubicin and methotrexate. Cancer Treat Rep (1987) 0.77
Characterization of cell lines derived from a multiply aneuploid human bladder transitional-cell carcinoma, UCRU-BL-13. Int J Cancer (1989) 0.77
The role of hepatitis B virus in the etiology of hepatocellular carcinoma in Australia. Aust N Z J Med (1983) 0.77
Fragment filtration: a method for the accurate determination of flow cytometric kinetic data from bone marrow aspirates. Exp Hematol (1986) 0.77
Localisation of satellite DNA sequences on human metaphase chromosomes using bromodeoxyuridine-labelled probes. Chromosoma (1988) 0.77
Surgery in patients with advanced germ cell malignancy following a clinical partial response to chemotherapy. J Surg Oncol (1983) 0.76
cis-Diamminedichloroplatinum-induced hypomagnesemia and renal magnesium wasting. Eur J Cancer Clin Oncol (1985) 0.76
High-dose methotrexate with leucovorin rescue, vinblastine, and bleomycin with or without tamoxifen in metastatic renal cell carcinoma. Cancer Treat Rep (1984) 0.76
Development of acute leukaemia in a patient with lymphosarcoma. N Z Med J (1973) 0.76
A comparative clinical trial of 5-azacytidine and guanazole in previously treated adults with acute nonlymphocytic leukemia. Cancer (1976) 0.76
Randomized trial of combination chemotherapy in hormone-resistant metastatic prostate carcinoma. Cancer Treat Rep (1985) 0.76
Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer. J Clin Oncol (1996) 0.75
Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy. Oncology (1989) 0.75
Relevance of the cytogenetic status in acute leukemia in adults. J Natl Cancer Inst (1973) 0.75
Marrow culture studies in adult acute leukemia at presentation and during remission. Blood (1977) 0.75